Bioline Rx (YP2.F) Q4 2024 Earnings

25NovConfirmed
Q4 2024
-0
-0
-0
0

Details

Expected EPS
-0.0027654848900000003
Actual EPS
0
Surprise EPS
0
Surprise Percent
+100%

Description

Bioline Rx (YP2.F) will report earnings of for Q4 2024 on November 25, 2024.

0 Comments

Share your thoughts